uz
Feedback
Introduction Modules | MW

Introduction Modules | MW

Kanalga Telegram’da o‘tish

Data Introduction Modules لمشاركة القناة - https://t.me/Introduction_Modules البوت - https://t.me/Introduction_ModulesBot القناة الرئيسية - @Medicine_Way2

Ko'proq ko'rsatish

📈 Telegram kanali Introduction Modules | MW analitikasi

Introduction Modules | MW (@introduction_modules) Arab til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 26 027 obunachidan iborat bo'lib, Tibbiyot toifasida 817-o'rinni va Misr mintaqasida 723-o'rinni egallagan.

📊 Auditoriya ko‘rsatkichlari va dinamika

невідомо sanasidan buyon loyiha tez o‘sib, 26 027 obunachiga ega bo‘ldi.

21 Iyun, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 28 ga, so‘nggi 24 soatda esa 5 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.

  • Tasdiqlash holati: Tasdiqlanmagan
  • Jalb etish (ER): Auditoriya o‘rtacha 3.45% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining N/A% ini tashkil etuvchi reaksiyalarni to‘playdi.
  • Post qamrovi: Har bir post o‘rtacha 0 marta ko‘riladi; birinchi sutkada odatda 0 ta ko‘rish yig‘iladi.
  • Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 0 ta reaksiya keladi.
  • Tematik yo‘nalishlar: Kontent module, general, microbiology, summary, بارا kabi asosiy mavzularga jamlangan.

📝 Tavsif va kontent siyosati

Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
Data Introduction Modules لمشاركة القناة - https://t.me/Introduction_Modules البوت - https://t.me/Introduction_ModulesBot القناة الرئيسية - @Medicine_Way2

Yuqori yangilanish chastotasi (oxirgi ma’lumot 22 Iyun, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.

26 027
Obunachilar
+524 soatlar
+107 kunlar
+2830 kunlar
Postlar arxiv
Carcinoma, Sarcoma - Page 8,...,11.m4a38.11 MB

Cancer genetics, Rev. Inflammation - Page 6,7.m4a42.90 MB

Grading,Staging,Prognosis,Causes.m4a42.57 MB

Neoplasia - Page 1,2,3.m4a40.56 MB

Repair_Complications,Lipofucin,Intro.m4a23.79 MB

Chronic inflammation, Repair - Page 12,13,1,2.m4a38.09 MB

Suppurative, NonSuppurative inflammation - Page 8,...,11.m4a42.69 MB

Calcification, Sup.inflammation - Page 13,14,8,9.m4a46.57 MB

Amyloidosis - Page 10,11,12.m4a37.82 MB

Inflammation - Page 1,2,3,4,5.m4a56.21 MB

Necrosis,Apoptosis,Tissue deposits - Page 9,10,11.m4a44.36 MB

Re,Irrevirsable cell injury - Page 6,7,8.m4a42.69 MB

Meta,Dysplasia, Cell injury - Page 3,4,5.m4a33.37 MB

Intro of cellular adaptation - Page 1,2.m4a31.58 MB

شرح د. محمد رفعت جينرال باثو 👇👇 #Pathology

20 - Disorder of blood flow.mp4

19 - Blood disorders 2 From hyperemia till embolism.mp4

18 - Disorders of blood flow 3 ischemia till shock.mp4

17 - Techniques 2020.mp4

16 - Septicemia , pyaemia , Toxemia 2020.mp4